Yonggao Mou
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen (NCT04547855) | Yonggao Mou | 2020-09-11 |
Track Yonggao Mou automatically
Every clearance here is in the API, with alerts when new ones post.